Brian Appleby, MD, Director, National Prion Disease Pathology Surveillance Center (NPDPSC)

Prion Disease Basics

Kevin Keough, Executive Director, Alberta Prion Research Institute

Prion Research Basics

Katrina Hallmark, PsyD, Neuropsychologist
Danielle Jordan, Autopsy Program Manager, NPDPSC

Bereavement Workshop

Richard Knight, BA, BM BCh, FRCP(E), Chair, Management Committee, the UK CJD Support Network

Keynote: Prion Diseases, An Overview

Simote Totauhelotu Foliaki, PhD, National Institute of Allergy and Infectious Diseases

Cerebral Neuronal Dysfunction associated with Human Prion Diseases

Graham S. Jackson, PhD, Medical Research Council Prion Unit, University College London

Development of a Quantitative, Real-time Protein-Misfolding by Cyclic Amplification (PMCA) Reaction

Gustavo Mostoslavsky, MD, PhD, Center for Regenerative Medicine/Boston University School of Medicine

Emmanuelle Vire, PhD, Medical Research Council Prion Unit at University College London

Investigating the Relevance of Blood DNA Methylation Signals for Disease Management in CJD

Kevin Keough, PhD, FCAHS, Executive Director, APRI

Alberta Prion Research Institute (APRI) Report

Miriam Warren, Histologist, Case Western Reserve University
Crissy Moskal, Administrative Manager
Danielle Jordan, Autopsy Program Manager

National Prion Disease Pathology Surveillance Center Update

Ryan Maddox, PhD, Epidemiologist, Prion and Public Health Office Division of High-Consequence Pathogens and Pathology

The 2019 Centers for Disease Control and Prevention (CDC) Report

Janine Kock & Brian Appleby, CJD Foundation Grants Committee, Members, CJD Foundation Board of Directors

CJD Foundation Grants Program

Steven E. Arnold, MD, Professor of Neurology, Harvard Medical School

Assessing Long-Term Stability of Cerebrospinal Fluid PrP Levels in Genetic Prion Disease Mutation Carriers

Roberto Chiesa, PhD, Laboratory of Prion Neurobiology, Department of Neuroscience

Nanoparticle-Mediated Brain Delivery of a Tetracationic Porphyrin with Potent Antiprion Activities

Jiyan Ma, PhD, Professor, Center for Neurodegenerative Science, Van Andel Institute

Determining the Therapeutic Potential of Anti-PrP Nanobody